Residual renal function and volume status in peritoneal dialysis patients: A conflict of interest?

Journal of Nephrology

Volumn 21, Issue 3, 2008, Pages 299-304

  Van Biesen, Wim ^a   Lameire, Norbert ^a   Verbeke, Francis ^a   Vanholder, Raymond ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Fluid overload; Peritoneal dialysis; Residual renal function; Volume status

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CONTRAST MEDIUM; GLUCOSE DEGRADATION PRODUCT; LOOP DIURETIC AGENT; PLACEBO; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1; DIALYSIS FLUID;

BIOCOMPATIBILITY; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIALYSATE; FLUID BALANCE; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; HYPERVOLEMIA; KIDNEY DYSFUNCTION; NEPHROTOXICITY; OTOTOXICITY; PERITONEAL DIALYSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SINGLE DRUG DOSE; SODIUM RESTRICTION; URINE VOLUME; CHRONIC KIDNEY FAILURE; ELECTROLYTE BALANCE; KIDNEY; PATHOPHYSIOLOGY;

DIALYSIS SOLUTIONS; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; WATER-ELECTROLYTE BALANCE;

EID: 52049098081     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol. 2001;12:2158-2162.
2. Huang WH, Chen KH, Hsu CW, et al. Residual renal function - one of the factors associated with arterial stiffness in peritoneal dialysis patients: Insight from a retrospective study in 146 peritoneal dialysis patients. Blood Purif. 2008;26:133-137.
3. Wang AY. The John F. Maher Award Recipient Lecture 2006. The "heart" of peritoneal dialysis: residual renal function. Perit Dial Int. 2007;27:116-124.
4. Han SH, Lee SC, Ahn SV, et al. Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients. Nephrol Dial Transplant. 2007;22:2653-2658.
5. Chandna SM, Kulinskaya E, Farrington K. A dramatic reduction of normalized protein catabolic rate occurs late in the course of progressive renal insufficiency. Nephrol Dial Transplant. 2005;20:2130-2138.
6. Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y. Time profiles of peritoneal and renal clearances of different uremic solutes in incident peritoneal dialysis patients. Am J Kidney Dis. 2005;46:512-519.
7. Chung SH, Heimburger O, Stenvinkel P, Qureshi AR, Lindholm B. Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. Nephrol Dial Transplant. 2003;18:590-597.
8. Van BW, Vanholder R, Veys N, Lameire N. Peritoneal dialysis in anuric patients: concerns and cautions. Semin Dial. 2002;15:305-310.
9. Davies SJ, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI. What really happens to people on long-term peritoneal dialysis? Kidney Int. 1998;54:2207-2217.
10. Jindal KK, Hirsch DJ. Long-term peritoneal dialysis in the absence of residual renal function. Perit Dial Int. 1996;16:78-81.
11. Maitra S, Burkart J, Fine A, et al. Patients on chronic peritoneal dialysis for ten years or more in North America. Perit Dial Int. 2000;20(suppl 2):S127-S133.
12. Lameire N, Van BW. Hypervolemia in peritoneal dialysis patients. J Nephrol. 2004;17(suppl 8):S58-S66.
13. Wang AY, Wang M, Woo J, et al. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int. 2002;62:639-647.
14. Ates K, Nergizoglu G, Keven K, et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int. 2001;60:767-776.
15. Brown EA, Davies SJ, Rutherford P, et al. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J Am Soc Nephrol. 2003;14:2948-2957.
16. Wang AY, Lam CW, Wang M, et al. Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients. Am J Kidney Dis. 2005;45:715-729.
17. Rodriguez-Carmona A, Perez-Fontan M, Garca-Naveiro R, Villaverde P, Peteiro J. Compared time profiles of ultrafiltration, sodium removal, and renal function in incident CAPD and automated peritoneal dialysis patients. Am J Kidney Dis. 2004;44:132-145.
18. Hidaka H, Nakao T. Preservation of residual renal function and factors affecting its decline in patients on peritoneal dialysis. Nephrology (Carlton). 2003;8:184-191.
19. Paniagua R, Amato D, Mujais S, et al. Predictive value of brain natriuretic peptides in patients on peritoneal dialysis: results from the ADEMEX trial. Clin J Am Soc Nephrol. 2008;3:407-415.
20. Sato Y, Takatsu Y, Kataoka K, et al. Serial circulating concentrations of C-reactive protein, interleukin (IL)-4, and IL-6 in patients with acute left heart decompensation. Clin Cardiol. 1999;22:811-813.
21. Chung SH, Heimburger O, Stenvinkel P, Bergstrom J, Lindholm B. Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. Nephrol Dial Transplant. 2001;16:2240-2245.
22. Ying WZ, Sanders PW. Dietary salt modulates renal production of transforming growth factor-beta in rats. Am J Physiol. 1998;274:F635-F641.
23. van Olden RW, Guchelaar HJ, Struijk DG, Krediet RT, Arisz L. Acute effects of high-dose furosemide on residual renal function in CAPD patients. Perit Dial Int. 2003;23:339-347.
24. Medcalf JF, Harris KP, Walls J. Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney Int. 2001;59:1128-1133.
25. Davies SJ, Woodrow G, Donovan K, et al. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol. 2003;14:2338-2344.
26. Konings CJ, Kooman JP, Schonck M, et al. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study. Kidney Int. 2003;63:1556-1563.
27. Rodriguez-Carmona A, Perez FM, Garcia LE, Garcia FT, Diaz CH. Use of icodextrin during nocturnal automated peritoneal dialysis allows sustained ultrafiltration while reducing the peritoneal glucose load: a randomized crossover study. Perit Dial Int. 2007;27:260-266.
28. Breborowicz A, Pawlaczyk K, Polubinska A, et al. Effect of peritoneal dialysis on renal morphology and function. Nephrol Dial Transplant. 2006;21:3539-3544.
29. Williams JD, Topley N, Craig KJ, et al. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int. 2004;66:408-418.
30. Montenegro J, Saracho R, Gallardo I, Martinez I, Munoz R, Quintanilla N. Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis. Nephrol Dial Transplant. 2007;22:1703-1708.
31. Haag-Weber M. Preservation of residual renal function with low GDP solutions. J Am Soc Nephrol. 2003;14:476A.
32. Fan SL, Pile T, Punzalan S, Raftery MJ, Yaqoob MM. Randomized controlled study of biocompatible peritoneal dialysis solutions: effect on residual renal function. Kidney Int. 2008;73:200-206.
33. Erixon M, Wieslander A, Linden T, et al. How to avoid glucose degradation products in peritoneal dialysis fluids. Perit Dial Int. 2006;26:490-497.
34. Ortiz A, Wieslander A, Linden T, et al. 3,4-DGE is important for side effects in peritoneal dialysis what about its role in diabetes. Curr Med Chem. 2006;13:2695-2702.
35. Szeto CC, Chow KM, Lam CW, et al. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products: a 1-year randomized control trial. Nephrol Dial Transplant. 2007;22:552-559.
36. Moist LM, Port FK, Orzol SM, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000;11:556-564.
37. Li PK, Chow KM, Wong TY, Leung CB, Szeto CC. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis: a randomized, controlled study. Ann Intern Med. 2003;139:105-112.
38. Wong TY, Szeto CC, Chow KM, Chan JC, Li PK. Prognostic role of serum ACE activity on outcome of type 2 diabetic patients on chronic ambulatory peritoneal dialysis. Am J Kidney Dis. 2002;39:1054-1060.
39. Hufnagel G, Michel C, Queffeulou G, Skhiri H, Damieri H, Mignon F. The influence of automated peritoneal dialysis on the decrease in residual renal function. Nephrol Dial Transplant. 1999;14:1224-1228.
40. Holley JL, Aslam N, Bernardini J, Fried L, Piraino B. The influence of demographic factors and modality on loss of residual renal function in incident peritoneal dialysis patients. Perit Dial Int. 2001;21:302-305.
41. Rabindranath KS, Adams J, Ali TZ, Daly C, Vale L, Macleod AM. Automated vs continuous ambulatory peritoneal dialysis: a systematic review of randomized controlled trials. Nephrol Dial Transplant. 2007;22:2991-2998.
42. Lui SL, Cheng SW, Ng F, et al. Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function. Kidney Int. 2005;68:2375-2380.
43. Baker RJ, Senior H, Clemenger M, Brown EA. Empirical aminoglycosides for peritonitis do not affect residual renal function. Am J Kidney Dis. 2003;41:670-675.
44. Blunden M, Zeitlin D, Ashman N, Fan SL. Single UK centre experience on the treatment of PD peritonitis: antibiotic levels and outcomes. Nephrol Dial Transplant. 2007;22:1714-1719.
45. McCullough PA, Stacul F, Becker CR, et al. Contrast-Induced Nephropathy (CIN) Consensus Working Panel: executive summary. Rev Cardiovasc Med. 2006;7:177-197.
46. Moranne O, Willoteaux S, Pagniez D, Dequiedt P, Boulanger E. Effect of iodinated contrast agents on residual renal function in PD patients. Nephrol Dial Transplant. 2006;21:1040-1045.
47. Dittrich E, Puttinger H, Schillinger M, et al. Effect of radio contrast media on residual renal function in peritoneal dialysis patients: a prospective study. Nephrol Dial Transplant. 2006;21:1334-1339.
48. Weisbord SD, Bernardini J, Mor MK, et al. The effect of coronary angiography on residual renal function in patients on peritoneal dialysis. Clin Cardiol. 2006;29:494-497.